Gene panel model predictive of outcome in men at high-risk of systemic progression and death from prostate cancer after radical retropubic prostatectomy.
about
Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomyCancer biomarker discovery: the entropic hallmark.Induction of prostatic intraepithelial neoplasia and modulation of androgen receptor by ETS variant 1/ETS-related protein 81.Molecular sampling of prostate cancer: a dilemma for predicting disease progression.A novel survival-based tissue microarray of pancreatic cancer validates MUC1 and mesothelin as biomarkers.Genetic markers associated with early cancer-specific mortality following prostatectomyCharacterization of transcriptional changes in ERG rearrangement-positive prostate cancer identifies the regulation of metabolic sensors such as neuropeptide Y.mRNA expression signature of Gleason grade predicts lethal prostate cancerProtein-coding and microRNA biomarkers of recurrence of prostate cancer following radical prostatectomyPrognostic value of discs large homolog 7 transcript levels in prostate cancer.Identification of proteomic biomarkers predicting prostate cancer aggressiveness and lethality despite biopsy-sampling error.Novel Gene Expression Signature Predictive of Clinical Recurrence After Radical Prostatectomy in Early Stage Prostate Cancer Patients.Novel dual-color immunohistochemical methods for detecting ERG-PTEN and ERG-SPINK1 status in prostate carcinoma.Prostate cancer genomics: towards a new understandingBiomarkers for prostate cancer: present challenges and future opportunities.An expression signature at diagnosis to estimate prostate cancer patients' overall survivalNovel Nine-Exon AR Transcripts (Exon 1/Exon 1b/Exons 2-8) in Normal and Cancerous Breast and Prostate Cells.Discovery of prostate cancer biomarkers by microarray gene expression profiling.Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer.Current challenges in development of differentially expressed and prognostic prostate cancer biomarkers.The role of treatment modality on the utility of predictive tissue biomarkers in clinical prostate cancer: a systematic review.Accurate patient selection and multimodal treatment offer the best therapeutic option in high-risk prostate cancer.ERG protein expression as a biomarker of prostate cancer.Molecular markers to guide primary radical treatment selection in localized prostate cancer.A four gene signature predictive of recurrent prostate cancer.Clinical variability and molecular heterogeneity in prostate cancer.Topoisomerase 2 Alpha Cooperates with Androgen Receptor to Contribute to Prostate Cancer ProgressionAntisense transcription at the TRPM2 locus as a novel prognostic marker and therapeutic target in prostate cancer.Gene panel model predictive of outcome in patients with prostate cancer.Hypoxia on the Expression of Hepatoma Upregulated Protein in Prostate Cancer Cells.Identification of markers of prostate cancer progression using candidate gene expression.Expression profiling of prostate cancer tissue delineates genes associated with recurrence after prostatectomy.Increased gene copy number of ERG on chromosome 21 but not TMPRSS2-ERG fusion predicts outcome in prostatic adenocarcinomas.TMPRSS2-ERG gene fusion status in minute (minimal) prostatic adenocarcinoma.Genomic predictors of prostate cancer therapy outcomes.TOP2A and EZH2 Provide Early Detection of an Aggressive Prostate Cancer Subgroup.Pixelated spatial gene expression analysis from tissue.Frequently rearranged and overexpressed δ-catenin is responsible for low sensitivity of prostate cancer cells to androgen receptor and β-catenin antagonists.Relevance of cohort design for studying the frequency of the ERG rearrangement in prostate cancer
P2860
Q28534277-8AF6F8BD-9DFA-4D98-A170-AACD7A714651Q30496149-8650267C-D2E7-4238-ADFC-58A8E4068B44Q33507490-6F420DEF-BCE4-4507-921C-B0647067A3E0Q33541296-14BBA6B5-5772-4625-98A0-6B1375A486F0Q34335982-CC8D0967-29B2-42A9-81B0-57F89315CDFEQ34340799-32F40094-1596-4F41-9E8D-ACFCCC7EF2A8Q34580034-E13BA15E-D1CC-478B-9F24-3741FF4B1BCCQ35023464-89C4B98D-7D7F-4B53-BFEA-C7061292E281Q35070161-B8CB6894-B61C-4C18-8A0A-26A1B0D26C10Q35070576-0B733EDC-C3D1-4BB2-8DC6-1B8F0B65CCF4Q35678391-E05EC173-A44E-477B-8BFC-5283003D72E8Q36043833-52F1FA13-26A0-4C0F-AA85-40FD706B5A4BQ36901964-10CE1EE0-5A39-449D-AAD6-E3CF27347E27Q37292004-B410A207-9963-460C-9B03-39B53DE7D894Q37474443-160209D6-F04C-40B8-A5EC-01F98B3EA827Q37578965-853E7A31-2B08-46E4-9DB5-01782E3F6629Q37631437-F444B7B6-05A4-45EC-A2BC-0443FF888BAFQ37656262-F61FDD7C-44B1-4E01-9431-A0D226536AC5Q38021384-F633C991-1688-4248-9E8E-C789996A9414Q38042634-49C82024-9E00-4A77-A198-087B54EC2AA0Q38063121-8A5F5ED4-BB02-4AF2-9E43-B903B208EF45Q38123201-EA1B5354-B0C6-4C70-A61E-87A3655E3DC5Q38165243-D9E9070E-6387-4862-A242-6CF1B791E544Q38226242-17CE8B55-CDA2-4EB9-8376-8EDF0A577A5DQ38783018-B729F942-3AF1-4235-B35E-BAF5BF220798Q38808811-7E859B64-B6F2-4329-8FBD-AD5CE23973D5Q38820055-FB292991-90EE-4C33-BAD1-AEBD8C2F7B97Q38984564-58705780-AE8A-4AD5-94D7-95917D4509E3Q39403730-C6D9EF53-791D-4A4F-AE90-6609FFD75BDFQ39631128-B91964DC-E064-43CD-BCCB-CE43B87419A5Q40177572-5824F497-EFB6-4962-A15E-1E684D6C785DQ40369700-767A40D2-A331-4B83-AC47-D80FA77C2BDEQ41854285-9BABB407-13AE-4928-B38C-DEDBD9AF2C14Q42126017-0995A1FC-4947-45C0-93FF-DBD2A1B85D4DQ44958045-40F1F5E4-BE0D-40D1-85AE-A1B33109FAC7Q46838481-532801F3-3BCD-49D3-84F9-CDF445057844Q48240151-19A3FCA5-236B-4A38-BE95-9C555B3C3A57Q54936285-49B3DC09-2646-4E24-BF23-C9E219664670Q57693358-12A334B1-1FBB-4B36-B331-85232D8D020D
P2860
Gene panel model predictive of outcome in men at high-risk of systemic progression and death from prostate cancer after radical retropubic prostatectomy.
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Gene panel model predictive of ...... ical retropubic prostatectomy.
@ast
Gene panel model predictive of ...... ical retropubic prostatectomy.
@en
type
label
Gene panel model predictive of ...... ical retropubic prostatectomy.
@ast
Gene panel model predictive of ...... ical retropubic prostatectomy.
@en
prefLabel
Gene panel model predictive of ...... ical retropubic prostatectomy.
@ast
Gene panel model predictive of ...... ical retropubic prostatectomy.
@en
P2093
P2860
P356
P1476
Gene panel model predictive of ...... ical retropubic prostatectomy.
@en
P2093
C D Savci-Heijink
Eati Basal
Eric Bergstralh
Eric W Klee
Farhad Kosari
George Vasmatzis
Irina V Kovtun
Jan-Marie Munz
John C Cheville
Laureano J Rangel
P2860
P304
P356
10.1200/JCO.2007.15.6752
P407
P577
2008-08-01T00:00:00Z